Retour
76
43
Fourchette du Jour
33,02 €
38,00 €
Fourchette 52 Semaines
15,49 €
38,06 €
Volume
200
Moyenne 50J / 200J
34,65 €
/
29,90 €
Clôture Précédente
33,02 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 2,9 | 0,2 |
| P/B | 1,5 | 3,0 |
| ROE % | 71,4 | 3,5 |
| Net Margin % | 51,1 | 3,8 |
| Rev Growth 5Y % | 204,7 | 9,7 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,00 €
0,00 € – 0,00 €
|
5,89B | 0 |
| FY2029 |
25,26 €
15,23 € – 38,31 €
|
4,46B | 1 |
| FY2028 |
6,68 €
4,03 € – 10,14 €
|
2,45B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-18 | -0,06 € | -0,01 € | +81,5% |
| 2025-11-13 | -0,12 € | -0,10 € | +13,8% |
| 2025-06-30 | 0,16 € | 0,11 € | -29,6% |
| 2025-03-31 | 1,03 € | 1,15 € | +11,7% |
| 2024-12-31 | -0,06 € | -0,03 € | +43,9% |
| 2024-09-30 | -0,06 € | -0,02 € | +64,7% |
| 2024-06-30 | -0,07 € | -0,07 € | -2,7% |
| 2024-03-31 | -0,08 € | -0,06 € | +23,0% |
Dividend History
1 yr streakYield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 10, 2019 | May 16, 2019 | 0,16 € | 0,56% |
Points Clés
Revenue grew 204,66% annually over 5 years — strong growth
ROE of 71,38% indicates high profitability
Net margin of 51,14% shows strong profitability
Debt/Equity of 0,04 — conservative balance sheet
Negative free cash flow of 0,0
P/E of 2,87 — trading at a low valuation
Croissance
Revenue Growth (5Y)
204,66%
Revenue (1Y)674,85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
71,38%
ROIC50,31%
Net Margin51,14%
Op. Margin68,44%
Sécurité
Debt / Equity
0,04
Current Ratio4,78
Interest Coverage36,10
Valorisation
P/E Ratio
2,87
Forward P/E23,00
P/B Ratio1,49
EV/EBITDA1,44
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 674,85% | Revenue Growth (3Y) | 79,92% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 110,91% |
| Revenue Growth (5Y) | 204,66% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,99B | Net Income (TTM) | 1,02B |
| ROE | 71,38% | ROA | 39,70% |
| Gross Margin | 97,04% | Operating Margin | 68,44% |
| Net Margin | 51,14% | Free Cash Flow (TTM) | 0,0 |
| ROIC | 50,31% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 4,78 |
| Interest Coverage | 36,10 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 1 yrs | ||
| Valuation | |||
| P/E Ratio | 2,87 | Forward P/E | 23,00 |
| P/B Ratio | 1,49 | P/S Ratio | 1,47 |
| PEG Ratio | -0,04 | Forward PEG | N/A |
| EV/EBITDA | 1,44 | Fwd EV/EBITDA | N/A |
| Forward P/S | 2,43 | Fwd Earnings Yield | 4,35% |
| FCF Yield | 0,00% | ||
| Market Cap | 2,93B | Enterprise Value | 1,96B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,99B | 257,35M | 616,00M | 228,29M | 23,15M |
| Net Income | 1,02B | -177,08M | 229,25M | -11,18M | -119,79M |
| EPS (Diluted) | 11,52 | -2,00 | 2,59 | -0,13 | -1,36 |
| Gross Profit | 1,94B | 230,37M | 526,37M | 153,97M | -31,92M |
| Operating Income | 1,36B | -228,51M | 252,64M | -17,44M | -139,72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,57B | 1,11B | 1,19B | 858,31M | 897,73M |
| Total Liabilities | 606,62M | 216,74M | 139,50M | 72,07M | 109,05M |
| Shareholders' Equity | 1,96B | 894,94M | 1,05B | 786,24M | 788,68M |
| Total Debt | 72,24M | 54,23M | 4,98M | 10,04M | 15,88M |
| Cash & Equivalents | 1,04B | 512,93M | 611,57M | 805,39M | 848,41M |
| Current Assets | 2,48B | 1,01B | 1,15B | 820,84M | 861,79M |
| Current Liabilities | 519,47M | 175,66M | 124,97M | 70,88M | 101,27M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Heavy Grower
#15 of 77
#54 of 203
Activité Récente
Sorti
Contrarian Investing (David Dreman)
Mar 26, 2026
Entré
Capital Heavy Grower
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Value Investing (Warren Buffett)
Mar 24, 2026